FDA approves generic version of Zerit HIV treatment

ROCKVILLE, Md. The Food and Drug Administration has approved a generic version of Bristol-Myers Squibb’s Zerit, agency records show.

The agency approved Matrix Labs’ stavudine capsules in 30 mg and 40 mg strengths. The capsules are used to treat HIV infection.

The branded version of the drug had sales of $155 million in 2006, according to Bristol financial data. Aurobindo Pharmaceuticals and Hetero Drugs also make generic versions of Zerit.